Short Interest in Merck KGaA (OTCMKTS:MKKGY) Increases By 6,722.2%

Merck KGaA (OTCMKTS:MKKGY - Get Free Report) saw a large growth in short interest in the month of March. As of March 31st, there was short interest totalling 61,400 shares, a growth of 6,722.2% from the March 15th total of 900 shares. Based on an average daily volume of 285,700 shares, the short-interest ratio is currently 0.2 days. Approximately 0.0% of the shares of the company are sold short.

Merck KGaA Price Performance

OTCMKTS:MKKGY traded down $0.16 during trading hours on Friday, hitting $26.62. The company's stock had a trading volume of 69,065 shares, compared to its average volume of 138,414. The company has a market capitalization of $17.20 billion, a PE ratio of 16.43, a PEG ratio of 2.05 and a beta of 0.94. Merck KGaA has a 52-week low of $24.32 and a 52-week high of $39.17. The business's 50-day moving average is $27.87 and its two-hundred day moving average is $29.84. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.91 and a current ratio of 1.33.

Merck KGaA (OTCMKTS:MKKGY - Get Free Report) last issued its quarterly earnings data on Thursday, March 6th. The company reported $0.54 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.47 by $0.07. Merck KGaA had a return on equity of 10.41% and a net margin of 12.89%. The firm had revenue of $5.78 billion during the quarter, compared to analysts' expectations of $5.40 billion. As a group, research analysts anticipate that Merck KGaA will post 1.87 EPS for the current fiscal year.

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.